Evaluation of the Efficacy of the Use MD Tissue Collagen Medical Device in the Infiltrative Treatment of Greater Trochanter Pain Syndrome (GTPS)

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

September 13, 2021

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2023

Conditions
Greater Trochanteric Pain SyndromeGTPS - Greater Trochanteric Pain SyndromeTendon DisorderPertrochanteric FractureGluteal TendinitisGluteal Muscles
Interventions
DEVICE

MD Tissue Collagen Medical Device

"The Experimental Group will be treated with 2-mL volume ultrasound-guided infiltration of: MD-Tissue (GUNA, Milan-Italy). Composition for 2 ml: collagen 100 micrograms Subjects will be treated with No.1 infiltration per week for 3 consecutive weeks. The infiltrations will be performed in an echoguided mode.~MD-Tissue Collagen Medical Device will be infiltrated into the trochanteric bursa and at the level of the tendons of the gluteus minimus and gluteus medius, particularly at the level of the most degenerated insertional areas."

Trial Locations (1)

20122

Gaetano Pini CTO, Milan

All Listed Sponsors
lead

Guna S.p.a

INDUSTRY

NCT05486078 - Evaluation of the Efficacy of the Use MD Tissue Collagen Medical Device in the Infiltrative Treatment of Greater Trochanter Pain Syndrome (GTPS) | Biotech Hunter | Biotech Hunter